718 results on '"Demar, Magalie"'
Search Results
302. Development of a case fatality prognostic score for HIV-associated histoplasmosis.
- Author
-
Françoise, Ugo, Nacher, Mathieu, Bourne-watrin, Morgane, Epelboin, Loïc, Thorey, Camille, Demar, Magalie, Carod, Jean-François, Djossou, Félix, Couppié, Pierre, and Adenis, Antoine
- Subjects
- *
HISTOPLASMOSIS , *RECEIVER operating characteristic curves , *C-reactive protein - Abstract
• Histoplasmosis case fatality score (HFS) predicts mortality at 30 days of treatment. • HFS is the first HIV-associated histoplasmosis prognostic score. • The criteria are performance and mental status, dyspnea, C-reactive protein, cytopenia, and chest X-ray. • An HFS <5 is associated with 30-day mortality <5% and >33% when HFS ≥5. • HFS may help clinicians optimize antifungal induction and reduce early mortality. The burden of histoplasmosis is as great as that of tuberculosis in Latin America and the attributable mortality is even higher. A better assessment of severity could help reduce mortality. From the French Guiana HIV-histoplasmosis database, we attempted to identify factors associated with 30-day death after antifungal drug initiation and constructed a prognostic score. We evaluated its discrimination performance using several resampling methods. Of the 415 patients included, 56 (13.5%) died within 30 days of treatment. The fatality-associated factors were performance status ≥3, altered mental status, dyspnea, C-reactive protein ≥75 mg/l, hemoglobin <9 g/dl and/or a platelet <100000/ml, and an interstitial lung pattern on chest X-ray. We constructed a 12-point prognostic score. A threshold ≥5 classified patients as alive or dead at 30 days with a sensitivity of 84%, a specificity of 81%, a positive predicted value of 40%, and a negative predicted value of 97%. The area under the curve of the receiver operating characteristic curves from the different resamples were stable between 0.88 and 0.93. The histoplasmosis case fatality score, which is easy and inexpensive to perform, is a good tool for assessing severity and helping in the choice of induction therapy. An external validation remains necessary to generalize these results. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
303. First Case of Emergence of Atovaquone Resistance in Plasmodium falciparumduring Second-Line Atovaquone-Proguanil Treatment in South America
- Author
-
Legrand, Eric, Demar, Magalie, Volney, Béatrice, Ekala, Marie-Thérèse, Quinternet, Marc, Bouchier, Christiane, Fandeur, Thierry, Rogier, Christophe, Carme, Bernard, Puijalon, Odile Mercereau, and Esterre, Philippe
- Published
- 2007
- Full Text
- View/download PDF
304. Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana.
- Author
-
Houcke, Stéphanie, Pujo, Jean Marc, Vauquelin, Segolene, Ngoula, Guy Roger Lontsi, Matheus, Severine, NkontCho, Flaubert, Pierre-Demar, Magalie, Gutiérrez, José María, Resiere, Dabor, Hommel, Didier, and Kallell, Hatem
- Subjects
- *
SNAKEBITES , *ANTIVENINS , *POISONS , *SNAKE venom , *HEALTH facilities , *STROKE units , *BLOOD coagulation disorders - Abstract
Background: Snakebite (SB) envenoming is an acute emergency requiring an early care delivery. We aimed to search for the time to reach healthcare facilities in various regions of French Guiana (FG) and to assess the impact of time to antivenom (AV) on the correction of coagulation parameters in these patients. Methodology: This is a prospective observational study conducted in Cayenne General Hospital between January 1st, 2016, and July 31st, 2022. We included all patients hospitalized for SB envenoming less than 48h after the bite, and receiving antivenom (AV). We assessed the time lapse between SB and medical attention and the time needed to return of the coagulation parameters to normal. Principal findings: Overall, 119 patients were investigated, and 48.7% were from remote areas. The median time from SB to AV therapy was 09:15 h (05:32–17:47). The time was longer in patients from remote rural locations. AV was dispensed within the first six hours after the SB in 45 cases (37.8%). Time from SB to reaching normal plasma fibrinogen concentration was 23:27 h (20:00–27:10) in patients receiving AV≤6h vs. 31:23 h (24:00–45:05) in those receiving AV>6h (p<0.001). Whereas, the time from AV administration to reach normal fibrinogen dosage was similar in the two groups. Conclusions: Patients from rural settings in FG suffer from a delay in AV administration after SB envenoming leading to an extended time in which patients are coagulopathic. Once AV is administered, clotting parameters recover at a similar rate. Supplying remote healthcare facilities with AV and with medical teams trained in its use should be planned. Author summary: Snakebite envenoming is a public health concern in the Amazon region. It represents an acute medical emergency needing early care such as stroke, severe trauma, myocardial infarction, etc. Antivenoms are the most effective treatment of snakebite envenomings. They are part of the WHO List of essential medicines and should be available in any primary health care where snakebite victims are managed. In this context, less than 6 hours delay between the snakebite and the antivenom administration is needed for a maximal chance to prevent and reverse most of the toxic effects of the snake venom. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
305. Primary or secondary prevention of HIV-associated histoplasmosis during the early antiretrovirals for all era.
- Author
-
Nacher, Mathieu, Le Turnier, Paul, Abboud, Philippe, Françoise, Ugo, Lucarelli, Aude, Demar, Magalie, Djossou, Félix, Epelboin, Loïc, Couppié, Pierre, and Adenis, Antoine
- Subjects
- *
HISTOPLASMOSIS , *SECONDARY prevention , *HIV infections , *HIGHLY active antiretroviral therapy , *ANTIRETROVIRAL agents - Abstract
Given the high incidence of disseminated histoplasmosis in the profoundly immunosuppressed, the question of primary prophylaxis against histoplasmosis for patients with advanced HIV in endemic areas should be reconsidered until I Histoplasma i antigen tests become widely available. Although most studies actually concern symptomatic patients, the natural history of HIV-associated progressive disseminated histoplasmosis is presumably often gradual; as the immunity gradually declines, the fungal burden gradually increases, and the intensity of symptoms, especially those impairing vital functions, grows. Shows that in the past decade, the yearly number patients with disseminated histoplasmosis declined and that the delay between HIV diagnosis and histoplasmosis diagnosis also declined. Nevertheless, since the "treat all" strategy in 2016, there were 17 histoplasmosis cases, 5/17 were patients on HAART and 3/5 developed histoplasmosis over a year after their HIV diagnosis. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
306. Impact of Lipoprotein(a) on Macrovascular Complications of Diabetes in a Multiethnic Population in the French Amazon.
- Author
-
Dordonne, Sabrina, Mergeayfabre, Mayka, Hafsi, Nezha, Ntoutoum, Andre, Salazar-Cardozo, Clara, Casse, Olivier, Hounnou, Marianne, Adenis, Antoine, Aurelus, Jean-Markens, Misslin-Tristch, Caroline, Carod, Jean-François, De Toffol, Bertrand, Lienne, Jean François, Demar, Magalie, Nacher, Mathieu, and Sabbah, Nadia
- Subjects
- *
FRENCH people , *DIABETES complications , *CARDIOVASCULAR diseases risk factors , *ETHNIC groups , *TYPE 2 diabetes - Abstract
Background and Aims. In French Guiana, the prevalence of diabetes is around 10%, and cardio and neurovascular pathologies are the first medical cause of early mortality. Lipoprotein(a) (Lp(a)) is described in the literature as a risk factor independent of other cardiovascular risk factors, but there are important interindividual differences, especially according to ethnicity. The objective of this study was to investigate the association of Lp(a) and macrovascular complications in a multiethnic population of patients with diabetes in the French Amazon. Materials and Methods. Since May 2019, 1243 patients were screened 806 of whom had Lp(a) determination. We compared the prevalence of macrovascular complications in three groups according to Lp(a) concentration: between 0 and 75 mg/mL, between 76 and 300 mg/mL, and >300 mg/mL. Results. 712 patients in the study had type 2 diabetes (88.34% of the sample). A history of hypertension was significantly associated with greater Lp(a) levels. Lp(a) concentration was greater among Creole ethnic groups. No association was found between Lp(a) levels and macrovascular complications in the Lp a > 300 mg/mL group. Conclusions. These results do not replicate findings in mostly Caucasian populations suggesting that the Lp(a) threshold for, or the link with, cardiovascular risk may be different given the predominantly African origin of the French Guianese population. Further studies should study genetic polymorphisms in our population. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
307. Novel Species of Brucella Causing Human Brucellosis, French Guiana.
- Author
-
About, Frédégonde, Pastre, Theo, Boutrou, Mathilde, Martinez, Alex Yahiaoui, Melzani, Alessia, Peugny, Sandrine, Michaud, Céline, Sami Zouaoui, Carage, Thierry, Rose, Vincent Sainte, Demar, Magalie, Lavigne, Jean-Philippe, Djossou, Félix, O'Callaghan, David, Epelboin, Loïc, and Keriel, Anne
- Subjects
- *
BRUCELLA , *BRUCELLOSIS , *SPECIES , *SYMPTOMS , *BRAZILIANS , *NON-self-governing territories , *HUMAN experimentation - Abstract
Human brucellosis is a zoonoses caused by bacteria of the genus Brucella. Infection results in subacute or chronic debilitating disease with nonspecific clinical manifestations and is often associated with consuming unpasteurized dairy products. We report 2 cases of brucellosis in male patients who were hospitalized in distinct towns of French Guiana, an overseas territory of France located on the northeastern shore of South America. Both men were citizens of Brazil working as clandestine goldminers in the deep Amazonian rainforest. Characterization of the 2 bacterial isolates revealed that they represent a potential new species of Brucella. Medical practitioners working in contact with wildlife in this region of the world should be aware of the existence of these pathogens and the potential for human infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
308. Using pentamidine to treat cutaneous leishmaniasis in children: a 10-year study in French Guiana.
- Author
-
Heleine, Melissa, Elenga, Narcisse, Njuieyon, Falucar, Martin, Elise, Piat, Camille, Pansart, Chloé, Couppie, Pierre, Hernandez, Miguel, Demar, Magalie, and Blaizot, Romain
- Subjects
- *
CUTANEOUS leishmaniasis , *FRENCH people - Abstract
There are little data on pentamidine as a treatment for paediatric cutaneous leishmaniasis (CL). The objective of this study was to describe the effectiveness and safety of pentamidine over a 10-year period. Every child seen in French Guiana between 2010 and 2020 with proven CL and treated with pentamidine was included. In total, 55 children met the inclusion criteria – 23 girls and 32 boys. There were 38 patients (38/55, 69%) with a > 50% improvement at 1 month after pentamidine treatment and a complete cure at 3 months; 16 children had a < 50% improvement at 1 month and were given a second dose. Of these 16, 8 showed a complete cure at 3 months, 5 were lost to follow-up and 3 showed therapeutic failure at 3 months. The overall cure rate was 84% (46/55) after one or two doses. In terms of the safety of pentamidine, no severe adverse events (grade ≥ 3) were reported. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
309. Establishing the proportion of severe/moderately severe vs mild cases of progressive disseminated histoplasmosis in patients with HIV.
- Author
-
Nacher, Mathieu, Adenis, Antoine, Blaizot, Romain, Abboud, Philippe, Le Turnier, Paul, Françoise, Ugo, Lucarelli, Aude, Demar, Magalie, Djossou, Félix, Epelboin, Loïc, and Couppié, Pierre
- Subjects
- *
HISTOPLASMOSIS , *HIV-positive persons , *AMPHOTERICIN B , *EARLY death , *CD4 lymphocyte count , *ITRACONAZOLE - Abstract
Background: Progressive disseminated histoplasmosis remains a major but neglected cause of death among patients with advanced HIV. Recently, aiming to reduce avoidable deaths, the Pan American Health Organization issued the first diagnosis and treatment guidelines for HIV-associated histoplasmosis. But what proportion of progressive disseminated histoplasmosis in HIV-infected patients is severe is currently not known. Because this proportion influences treatment needs, we aimed to estimate this in a cohort of 416 patients in French Guiana. Methods: We used the definition in the recent PAHO/WHO guidelines for severity. We used regression modelling to predict the impact of CD4 count on the proportion of severe cases. In a territory where treatment cost is not a limiting factor and where histoplasmosis is well known, we assumed that clinicians' initial treatment reflected their perception about the severity of the case and therefore, the needs for different treatments. Results: Using these definitions, since the beginning, there were 274 (65.9%) severe/moderately severe cases and 142 (34.1%) mild cases. In practice 186 cases were treated with deoxycholate or liposomal amphotericin B (44.7%) and 230 (55.3%) cases treated with itraconazole as first line treatment. The Kappa concordance measure between the guideline definition and the actual treatment given was 0.22. There was a 9% risk difference for death within 30 days of antifungal treatment initiation between severe/moderately severe and mild cases. Over threequarters (77%) of early deaths were attributed to severe/moderately severe cases. Conclusions: This is the only rigorous estimate of the proportion of severe/moderately severe cases of progressive disseminated histoplasmosis in symptomatic HIV patients on the largest published cohort. These numbers may help defend budget needs for rapid diagnostic tests and liposomal amphotericin B. Author summary: What proportion of progressive disseminated histoplasmosis in HIV-infected patients is severe is currently not known. Because this proportion influences treatment needs, we aimed to estimate this in a cohort of 416 patients in French Guiana. We used the definition in the recent PAHO/WHO guidelines for severity. In a territory where treatment cost is not a limiting factor and where histoplasmosis awareness is high, we assumed that clinicians' initial treatment reflected their perception of severity and therefore, the needs for different treatments. Using these definitions, since the beginning, there were 274 (65.9%) severe/moderately severe cases and 142 (34.1%) mild cases. In practice 186 cases were treated with deoxycholate or liposomal amphotericin B (44.7%) and 230 (55.3%) cases treated with itraconazole as first line treatment. The Kappa concordance measure between guidelines and treatment was 0.22. There was a 9% risk difference for death within 30 days of antifungal treatment initiation between severe/moderately severe and mild cases. Over threequarters (77%) of early deaths were attributed to severe/moderately severe cases. This is the only rigorous estimate of the proportion of severe/moderately severe cases of progressive disseminated histoplasmosis in symptomatic HIV patients on the largest published cohort. These numbers may help defend budget needs for rapid diagnostic tests and liposomal amphotericin B. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
310. Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008–2018.
- Author
-
Chaptal, Milène, Andrejak, Claire, Bonifay, Timothée, Beillard, Emmanuel, Guillot, Geneviève, Guyomard-Rabenirina, Stéphanie, Demar, Magalie, Trombert-Paolantoni, Sabine, Jacomo, Veronique, Mosnier, Emilie, Veziris, Nicolas, Djossou, Felix, and Epelboin, Loïc
- Subjects
- *
LUNG infections , *MYCOBACTERIA , *LATENT infection , *BURULI ulcer , *EPIDEMIOLOGY , *MYCOBACTERIUM tuberculosis , *MYCOBACTERIUM avium paratuberculosis - Abstract
Introduction: Unlike diseases caused by Mycobacterium tuberculosis, M. leprae and M. ulcerans, the epidemiology of pulmonary non-tuberculous mycobacteria (PNTM) has not received due attention in French Guiana. The main objective of the current study was to define the incidence of these PNTM infections: NTM pulmonary diseases (NTM-PD) and casual PNTM isolation (responsible of latent infection or simple colonization). The secondary objectives were to determine species diversity and geographic distribution of these atypical mycobacteria. Methods: A retrospective observational study (2008–2018) of French Guiana patients with at least one PNTM positive respiratory sample in culture was conducted. Patients were then classified into two groups: casual PNTM isolation or pulmonary disease (NTM-PD), according to clinical, radiological and microbiological criteria defined by the American Thoracic Society / Infectious Disease Society of America (ATS / IDSA) in 2007. Results: 178 patients were included, out of which 147 had casual PNTM isolation and 31 had NTM-PD. Estimated annual incidence rate of respiratory isolates was 6.17 / 100,000 inhabitants per year while that of NTM-PD was 1.07 / 100,000 inhabitants per year. Among the 178 patients, M. avium complex (MAC) was the most frequently isolated pathogen (38%), followed by M. fortuitum then M. abscessus (19% and 6% of cases respectively), the latter two mycobacteria being mainly found in the coastal center region. Concerning NTM-PD, two species were mainly involved: MAC (81%) and M. abscessus (16%). Discussion/Conclusion: This is the first study on the epidemiology of PNTM infections in French Guiana. PNTM's incidence looks similar to other contries and metropolitan France and NTM-PD is mostly due to MAC and M.abscessus. Although French Guiana is the French territory with the highest tuberculosis incidence, NTM should not be overlooked. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
311. Spectrum of skin diseases in Maroon villages of the Maroni area, French Guiana.
- Author
-
Valentin, Julie, Niemetzky, Florence, Gaillet, Melanie, Michaud, Celine, Carbunar, Aurel, Demar, Magalie, Couppie, Pierre, and Blaizot, Romain
- Subjects
- *
SKIN diseases , *CUTANEOUS leishmaniasis , *SCABIES , *MEDICAL databases , *SNAKEBITES , *NOSOLOGY , *COMMUNICABLE diseases - Abstract
Background: Due to their genetic characteristics and their high exposure to infectious diseases, Maroons are likely to suffer from a specific spectrum of skin diseases. However, skin disorders have never been explored in this population. We aimed to describe all skin diseases in Maroon villages of the Maroni region in French Guiana. Methods: This retrospective study concerned all patients who consulted in the remote health centers of Apatou, Grand‐Santi, Papaichton, and Maripasoula between October 5, 2017, and June 30, 2020. We included all patients registered with a skin disorder (International Classification of Diseases) in the medical database. We excluded patients whose diagnosis was invalidated after cross‐checking by a dermatologist. Results: A total of 4741 patients presented at least one skin disease, for 6058 different disorders. Nonsexually transmitted infections represented 71.6% of all diagnoses, followed by inflammatory diseases (9.8%) and bites/envenomations (4.6%). The three most frequent conditions were scabies, abscesses, and impetigo. Besides scabies, neglected tropical diseases (NTDs) were still prevalent as we reported 13 cases of leprosy and 63 cutaneous leishmaniasis. Atopic dermatitis (AD) represented only 2.5% of our diagnoses. Conclusions: With the exception of AD, which was less frequent among Maroons, these results are similar to those previously reported in Amerindians. Therefore, a common exposure to rainforest pathogens seems to induce a common spectrum of skin diseases dominated by infections. The high prevalence of NTDs requires specific public health actions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
312. Zoonoses and gold mining: A cross-sectional study to assess yellow fever immunization, Q fever, leptospirosis and leishmaniasis among the population working on illegal mining camps in French Guiana.
- Author
-
Douine, Maylis, Bonifay, Timothée, Lambert, Yann, Mutricy, Louise, Galindo, Muriel Suzanne, Godin, Audrey, Bourhy, Pascale, Picardeau, Mathieu, Saout, Mona, Demar, Magalie, Sanna, Alice, Mosnier, Emilie, Blaizot, Romain, Couppié, Pierre, Nacher, Mathieu, Adenis, Antoine, Suarez-Mutis, Martha, Vreden, Stephen, Epelboin, Loïc, and Schaub, Roxane
- Subjects
- *
YELLOW fever , *Q fever , *ZOONOSES , *LEPTOSPIROSIS , *GOLD mining - Abstract
Background: Most emerging pathogens are zoonoses and have a wildlife origin. Anthropization and disruption of ecosystems favor the crossing of inter-species barriers. We hypothesize that the marginalized population of undocumented goldminers in the Amazon is at risk of acquiring zoonoses. Method: A multicentric cross-sectional study included consenting gold-mining adult workers in 2019. A clinical examination recorded dermatological signs of leishmaniosis and past history of yellow fever vaccination. Biological tests were performed for yellow fever, Q fever and leptospirosis serologies. Additional blood samples from a previous study in 2015 were also tested for leptospirosis. Results: In 2019, 380 individuals were included in the study, along with 407 samples from the 2015 biological collection. The seroprevalence of leptospirosis was 31.0% [95%CI = 26.4–35.5] in 2015 and 28.1% [23.5–32.7] in 2019. The seroprevalence of Q fever was 2.9% [1.2–4.6]. The majority of participants reported being vaccinated against yellow fever (93.6%) and 97.9% had seroneutralizing antibodies. The prevalence of suspected active mucocutaneous leishmaniasis was 2.4% [0.8–3.9]. Discussion: These unique data shed new light on the transmission cycles of zoonoses still poorly understood in the region. They support the existence of a wild cycle of leptospirosis but not of Q fever. Leishmaniasis prevalence was high because of life conditions and tree felling. High yellow fever vaccine coverage was reassuring in this endemic area. In the era of global health, special attention must be paid to these vulnerable populations in direct contact with the tropical ecosystem and away from the health care system. Author summary: Many pathogens are zoonotic in origin and human transmission can occur via vector, direct contact, inhalation, absorption, among other routes enabling human-reservoir interaction. In Amazonia, the cycle of these pathogens (the reservoir, the mode of transmission ...) is not always well known. It is important to better understand these cycles in order to evaluate and anticipate the potential risk for human health, both on an individual and collective scale (risk of epidemic). In French Guiana, a French territory located in the Amazon, undocumented gold miners represent several thousand people from Brazil who work in very remote areas in the middle of the rainforest. Documenting several zoonotic diseases among this population living in the middle of biodiversity is very valuable to better understand these cycles but also to assess the impact for their own health and to identify risks for public health. This article provides new data for four zoonoses: Q-fever, leptospirosis, leishmaniasis and yellow fever in this population and discusses the contributions to the understanding of cycles and public health issues. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
313. High endemicity of Q fever in French Guiana: A cross sectional study (2007–2017).
- Author
-
Thill, Pauline, Eldin, Carole, Dahuron, Laureen, Berlioz-Artaud, Alain, Demar, Magalie, Nacher, Mathieu, Beillard, Emmanuel, Djossou, Félix, and Epelboin, Loïc
- Subjects
- *
Q fever , *COXIELLA burnetii , *ZOONOSES , *SERODIAGNOSIS - Abstract
Q fever (QF) is a zoonosis caused by Coxiella burnetii (Cb). French Guiana (FG) had a high incidence but no data have been published since 2006. The objective of this study was to update the incidence and epidemiological data on QF in FG. A retrospective study of all FG Q fever serodiagnosis between 2007 and 2017 was carried out. Among the 695 patients included, the M/F sex-ratio was 2.0 and the median age of 45.3 years (IQR 33.7–56.3). The annual QF incidence rate was 27.4 cases (95%CI: 7.1–47.7) per 100,000 inhabitants ranging from 5.2 in 2007 to 40.4 in 2010. Risk factors associated with Q fever compared to general population were male gender, being born in mainland France an age between 30 to 59 years-old and a residence in Cayenne and surroundings. The incidence of QF in FG remains high and stable and the highest in the world. Author summary: We present here a study showing the exceptional nature of the incidence of Q fever in Guyana. Indeed, this zoonosis due to the bacterium Coxiella burnetii, is a real public health problem in French Guiana, a French ultra-marine territory located in the North East of South America. The study found an endemic state with a stable incidence between 2010 and 2017 around 25–30 cases per 100,000 inhabitants per year. More than 90% of cases are concentrated in the territory's capital, Cayenne, and its surroundings. The risk factors for Q fever are being male, being between 30 and 59 years old, which are risk factors found elsewhere, but also living in Cayenne and its surroundings and being born in mainland France or Europe. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
314. Cryptosporidiosis outbreak in Amazonia, French Guiana, 2018.
- Author
-
Menu, Estelle, Mosnier, Emilie, Cotrel, Arnaud, Favennec, Loic, Razakandrainibe, Romy, Valot, Stéphane, Blanchet, Denis, Dalle, Frédéric, Costa, Damien, Gaillet, Mélanie, Demar, Magalie, and de Laval, Franck
- Subjects
- *
CRYPTOSPORIDIOSIS , *WATER pollution , *CRYPTOSPORIDIUM parvum , *PUBLIC health , *WATER supply - Abstract
Background: Cryptosporidiosis outbreaks in South America are poorly documented. In March 2018, 51 cases of cryptosporidiosis were reported in Maripasoula, a village located in a remote forest area along the border between Surinam and French Guiana. Method: To identify the origin of the epidemic, we performed epidemiological, microbiological, and environmental investigations. Only the cases involving diarrhoea and Cryptosporidium-positive stool were considered as bona fide, while cases involving diarrhoea and close contact with a confirmed case were classified as "possible". Results: We identified 16 confirmed cases and 35 possible ones. Confirmed cases comprised nine children (median age of 18 months, range: 6–21), one immunocompromised adult and six soldiers. One child required a hospitalisation for rehydration. All 16 Cryptosporidium stools were PCR positive, and sequencing of the gp60 gene confirmed only one Cryptosporidium hominis subtype IbA10G2. Tap water consumption was the only common risk factor identified. Contamination of the water network with Cryptosporidium parvum subtype IIdA19G2 was found. Conclusion: Water quality is a major public health issue in Amazonian French Guiana, especially for population at risk (children, people with comorbidity, travelers). For them, alternative water supply or treatment should be implemented. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
315. Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects.
- Author
-
Henry, Kim, Mayet, Aurélie, Hernandez, Miguel, Frechard, Guillaume, Blanc, Pierre-Antoine, Schmitt, Marion, André, Nathalie, Loreau, Jean-Marie, Ginouves, Marine, Prévot, Ghislaine, Couppié, Pierre, Demar, Magalie, and Blaizot, Romain
- Subjects
- *
CUTANEOUS leishmaniasis , *LEISHMANIA mexicana , *MILITARY personnel , *ILLEGAL logging , *MILITARY education , *SYMPTOMS , *INFECTION , *ACINETOBACTER infections - Abstract
Background: Cutaneous Leishmaniasis (CL) is endemic in French Guiana but cases are usually sporadic. An outbreak signal was issued on May 15th 2020 with 15 suspected cases after a military training course in the rainforest. An outbreak investigation was carried out. Methodology/Principal findings: Thirty cases were confirmed. Leishmania guyanensis was the most frequent species (90%). The most frequent presentation was ulcerative (90%). Lesions on the face and hands were frequent (40% each). Eight cases (26%) presented a poor outcome after treatment with pentamidine and required a second line with amphotericin B. Three of them required further treatments with meglumine antimoniate or miltefosine. Two spots within the training area were deemed as likely sites of contamination, due to illegal logging. The isolated Leishmania strains did not form a separate cluster. Participation in Week 13 of year 2020 was associated with infection (OR = 4.59 [1.10–19.83]; p = 0.016) while undergoing only the "Fighting" exercise was protective (OR = 0.1 [0–0.74]; p = 0.021). There was no association between infection and other risk factors at the individual level. The attack rate of Regiment B (14/105 = 13.3%) was significantly higher (OR = 4.22 [1.84–9.53], p = 0.0001) compared to Regiment A (16/507 = 3.2%). The attack rate during this training course (30/858 = 3.5%) was significantly higher (OR 2.29 [1.28–4.13]; p = 0.002) than for other missions in French Guiana during the same period (22/1427 = 1.5%). Conclusions: This outbreak could be explained by a combination of factors: climatic conditions around week 13, at-risk activities including night trainings, absence of impregnation, a lesser experience of rainforest duties in Regiment B and illegal logging attracting sandflies on military training grounds. Author summary: Cutaneous Leishmaniasis is caused by parasites of the Leishmania genus and infects humans after a sandfly bite. Outbreaks are rare and hard to investigate in isolated tropical areas. In this study, the authors explored the different possible origins of an outbreak of cutaneous leishmaniasis among soldiers training in the rainforest of French Guiana. The outbreak occurred in March 2020. Concerning the symptoms, several patients presented resistant infections and multiple lines of treatment, raising the issue of resistant Leishmania strains. The different strains isolated during the outbreak were not genetically closed, as far as routine PCR techniques would indicate. The authors looked for individual behaviours exposing soldiers to sandfly bites but none was significantly associated with infection. The authors found two spots in the military training areas where illegal logging probably increased the density of sandflies and put service members at risk. The 13th week of 2020 was associated to a higher risk of infection due to climatic conditions. This study shows how interactions between humans and the rainforest can increase the risk of parasitic outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
316. Review of diagnostic methods and results for HIV‐associated disseminated histoplasmosis: Pathologists are not sufficiently involved.
- Author
-
Nacher, Mathieu, Valdes, Audrey, Adenis, Antoine, Blaizot, Romain, Ugo, Françoise, Abboud, Philippe, Demar, Magalie, Djossou, Félix, Epelboin, Loïc, Misslin, Caroline, Blanchet, Denis, Couppié, Pierre, and Alsibai, Kinan Drak
- Subjects
- *
HISTOPLASMOSIS , *PATHOLOGISTS , *CEREBROSPINAL fluid , *ALIMENTARY canal , *BONE marrow - Abstract
Objectives: Disseminated histoplasmosis is a major killer of HIV‐infected persons in Latin America. Antigen detection, fungal culture and Polymerase Chain Reaction are often not available, but cytology and histology are present in most hospitals and may offer a diagnostic alternative. In this study, we review 34 years of clinical experience to describe the roles of cytology and histology in diagnosing disseminated histoplasmosis. Methods: Retrospective multicentric study of 349 patients between 1 January 1981 and 1 October 2014 with confirmed disseminated histoplasmosis. Results: Around 32/214 (14.9%) of samples were screened using cytopathology, as were 10/101 (9.9%) bronchoalveolar lavage samples and 5/61 (8.2%) of spinal fluid samples. The samples most commonly sent to pathology were liver biopsies, lower digestive tract and lymphnode biopsies; the greatest proportion of positive results were found in lower digestive tract (43/59 (72.9%) positives), lymph node (39/63 (66.1%)), and liver (38/75 (50.7%)) samples. Overall, 97.2% of bone marrow and 97% of bronchoalveolar lavage samples were directly examined by a mycologist. Positive direct examination was independently associated with death (aHR = 1.5 (95%CI = 1–2.2)). Conclusions: Opportunities for a rapid diagnosis were regularly missed, notably for bone marrow samples, which could have been examined using staining methods complementary to those of the mycologist. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
317. Kelch13 mutations in Plasmodium falciparum and risk of spreading in Amazon basin countries.
- Author
-
Mathieu, Luana C, Singh, Prabhjot, Monteiro, Wuelton Marcelo, Magris, Magda, Cox, Horace, Lazrek, Yassamine, Melo, Gisely C, Marchesini, Paola, Alexandre, Jean S F, Alvarez, Angel Manuel, Demar, Magalie, Douine, Maylis, Ade, Maria-Paz, Lacerda, Marcus V G, and Musset, Lise
- Subjects
- *
GENETIC mutation , *PLASMODIUM falciparum , *HUMAN migration patterns , *PLASMODIUM , *MALARIA , *COVID-19 , *DRUG therapy for malaria , *PROTOZOA , *PROTEINS , *RESEARCH , *RESEARCH methodology , *DRUG resistance , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *RESEARCH funding , *ANTIMALARIALS , *PHARMACODYNAMICS - Abstract
Background: The first potential focus for artemisinin resistance in South America was recently confirmed with the presence of the C580Y mutation in the Plasmodium falciparum kelch 13 gene (pfk13) in Guyana.Objectives: This study aimed to strengthen pfk13 monitoring in the Amazon basin countries, to compile the available data and to evaluate the risk of spreading of mutations.Methods: Sanger sequencing was done on 862 samples collected between 1998 and 2019, and a global map of pfk13 genotypes available for this region was constructed. Then, the risk of spreading of mutations based on P. falciparum case importation between 2015 and 2018 within countries of the Amazon basin was evaluated.Results: No additional pfk13 C580Y foci were identified. Few mutations (0.5%, 95% CI = 0.3%-0.8%) in the propeller domain were observed in the general parasite population of this region despite a high proportion of K189T mutations (49.1%, 95% CI = 46.2%-52.0%) in the non-propeller domain. Case information revealed two patterns of intense human migration: Venezuela, Guyana and the Roraima State in Brazil; and French Guiana, Suriname and the Amapá State in Brazil.Conclusions: There are few pfk13 mutant foci, but a high risk of dispersion in the Amazon basin, mainly from the Guiana Shield, proportionate to mining activities. Therefore, access to prompt diagnosis and treatment, and continuous molecular monitoring is essential in these geographical areas. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
318. Outbreak of Oropouche Virus in French Guiana.
- Author
-
Gaillet, Mélanie, Pichard, Clara, Restrepo, Johana, Lavergne, Anne, Perez, Lucas, Enfissi, Antoine, Abboud, Philippe, Lambert, Yann, Ma, Laurence, Monot, Marc, Demar, Magalie, Djossou, Felix, Servas, Véronique, Nacher, Mathieu, Andrieu, Audrey, Prudhomme, Julie, Michaud, Céline, Rousseau, Cyril, Jeanne, Isabelle, and Duchemin, Jean-Bernard
- Subjects
- *
VIRUSES , *RAIN forests , *FEVER , *ARBOVIRUSES , *BUNYAVIRUSES - Abstract
Oropouche fever is a zoonotic dengue-like syndrome caused by Oropouche virus. In August-September 2020, dengue-like syndrome developed in 41 patients in a remote rainforest village in French Guiana. By PCR or microneutralization, 23 (82.1%) of 28 tested patients were positive for Oropouche virus, documenting its emergence in French Guiana. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
319. Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021.
- Author
-
Vignier, Nicolas, Bérot, Vincent, Bonnave, Nathalie, Peugny, Sandrine, Ballet, Mathilde, Jacoud, Estelle, Michaud, Céline, Gaillet, Mélanie, Djossou, Félix, Blanchet, Denis, Lavergne, Anne, Demar, Magalie, Nacher, Mathieu, Rousset, Dominique, and Epelboin, Loïc
- Subjects
- *
GOLD miners , *SARS-CoV-2 , *VACCINATION , *GOLD mining , *COVID-19 - Abstract
An outbreak of severe acute respiratory syndrome coronavirus 2 caused by the Gamma variant of concern infected 24/44 (55%) employees of a gold mine in French Guiana (87% symptomatic, no severe forms). The attack rate was 60% (15/25) among fully vaccinated miners and 75% (3/4) among unvaccinated miners without a history of infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
320. Accuracy of SD Malaria Ag P.f/Pan® as a rapid diagnostic test in French Amazonia.
- Author
-
Pujo, Jean Marc, Houcke, Stéphanie, Lemmonier, Sarah, Portecop, Patrick, Frémery, Alexis, Blanchet, Denis, Djossou, Felix, Kallel, Hatem, and Demar, Magalie
- Subjects
- *
MALARIA , *DIAGNOSIS methods , *DIAGNOSIS , *BLOOD testing , *PLASMODIUM vivax - Abstract
Background: French Guiana (FG) is a French overseas territory where malaria is endemic. The current incidence rate is 0.74‰ inhabitants, and Plasmodium vivax is widely predominating even though Plasmodium falciparum is still present due to imported cases mainly from Africa. In FG, rapid diagnostic test (SD Malaria Ag P.f/Pan®) is based on the detection of pan-pLDH, PfHRP2, and PfHRP3 antigens, while in South America, the share of deletion of PfHRP2 gene is significantly increasing. Accordingly, the study questions the reliability of RDTs in the Amazonian context. Methods: The study is retrospective. It is conducted over 4 years and analysed 12,880 rapid diagnostic tests (RDTs) compared to concomitant Blood Film Tests (BFTs) sampled for malaria diagnosis. Results: The global assessment of the accuracy of SD Malaria Ag P.f/Pan® in the diagnostic of malaria shows both Positive and Negative Predictive Values (PPV and NPV) higher than 95%, except for PPV in the diagnosis of malaria to P. falciparum (88%). Overall, the concordance rate between RDT and BFT (positive/positive; negative/negative) was 99.5%. The PPV of the RDT in the follow-up of patients diagnosed with P. falciparum was the lowest during the first 28 days. The PPV of the RDT in the follow-up of patients diagnosed with P. vivax was the lowest during the first 21 days. The global sensitivity of SD Malaria Ag P.f/Pan® test was, on average, 96% (88.2–100) for P. falciparum and 93% (90.6–94.2) for P. vivax. The global specificity was 99.8% (99.5–100) for all included species. Conclusion: SD Malaria Ag P.f/Pan® is a reliable rapid test used for the first-line diagnosis in remote healthcare centres. The test results should be interpreted in the light of patient's recent medical history and the date of arrival to FG. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
321. Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019.
- Author
-
Cachera, Laurène, Adenis, Antoine, Guarmit, Basma, Rabier, Sébastien, Couppié, Pierre, Djossou, Felix, Epelboin, Loïc, Melzani, Alessia, Abboud, Philippe, Blanchet, Denis, Demar, Magalie, Alsibai, Kinan Drak, and Nacher, Mathieu
- Subjects
- *
FUNGAL communities , *MYCOSES , *HIV , *CRYPTOCOCCALES , *HOSPITAL patients - Abstract
Although the burden of histoplasmosis in patients with advanced HIV has been the focus of detailed estimations, knowledge about invasive fungal infections in patients living with HIV in an Amazonian context is somewhat scattered. Our goal was thus to adopt a broader view integrating all invasive fungal infections diagnosed over a decade in French Guiana. All patients hospitalized at Cayenne hospital from 1 January 2009 to 31 December 2018 with a proven diagnosis of invasive fungal infection were included (n = 227). Histoplasmosis was the most common (48.2%), followed by Cryptococcus infection (26.3%), and pneumocystosis (12.5%). For cryptococcal infection, there was a discordance between the actual diagnosis of cryptococcal meningitis n = (26) and the isolated presence of antigen in the serum (n = 46). Among the latter when the information was available (n = 34), 21(65.6%) were treated with antifungals but not coded as cryptococcocosis. Most fungal infections were simultaneous to the discovery of HIV (38%) and were the AIDS-defining event (66%). The proportion of major invasive fungal infections appeared to remain stable over the course of the study, with a clear predominance of documented H. capsulatum infections. Until now, the focus of attention has been histoplasmosis, but such attention should not overshadow other less-studied invasive fungal infections. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
322. Prevalence of intestinal parasite among patients attending two hospitals in French Guiana: A 6-year retrospective study.
- Author
-
Aboikoni, Alolia, Allaire, Manon, Louvel, Dominique, Blanchet, Denis, Dao, Thong, Carod, Jean-François, and Demar, Magalie
- Subjects
- *
INTESTINAL parasites , *GIARDIA lamblia , *PARASITIC diseases , *MIXED infections , *INTESTINAL infections , *INTESTINAL diseases - Abstract
Introduction: Intestinal parasitic diseases are a global health problem. Due to its equatorial climate, vast territory with isolated areas and the precariousness of its population, intestinal parasitosis is considered to be a major issue in French Guiana but only few data are available and these mainly focus on specific population. We aimed at determining the parasitic index and at describing the characteristics of these infections in order to develop preventive strategies. Material and methods: We retrospectively analysed all the parasitological samples recorded in the register of the two main laboratories of French Guiana between 2011 and 2016. The parasitic index was the percentage of parasitised patients in comparison with the total number of subjects studied. A patient who underwent several positive parasitological examinations was considered only once in the analysis at the time of the first sampling. Results: A total of 15,220 parasitological samples of 9,555 patients were analysed and 2,916 were positive in 1,521 patients. The average infestation rate and parasitic index were 19.2% and 16.0%, respectively. The parasitic index remained stable between 2011 (18.2%) and 2016 (18.3%). The patients were mainly men (66.4%), with a median age of 33.0 years (26.3% of patients were under 18 years of age) and lived mainly in the Central Agglomeration (48.2%) and in West Guiana (37.4%). Hookworms were the most common parasite (25.2%) followed by Entamoeba coli (13.3%), Strongyloides stercoralis (10.9%) and Giardia intestinalis (10.8%). Among the infected patients, 31.0% presented mixed infections and 67.5% of them had at least one pathogenic parasite. The patients aged from 0 to 18 years presented significantly more polyparasitism (30.9%) than monoparasitism (24.3%, p<0.001). Ancylostoma sp and Strongyloides stercoralis were mainly diagnosed during the rainy season (59.5% and 64.7% respectively), in men (78.6% and 81.1% respectively) and in patients aged from 18 to 65 years (86.6% and 76.6% respectively) whereas, Giardia intestinalis infected mostly children under 5 years (59.5%) of age. Conclusion: Although it may not be representative of the entire Guyanese population, the parasitic index remained high and stable from 2011 and 2016 and it justifies the need for an active prevention program as it was already done in the other French overseas departments such as Martinique and Guadeloupe. Author summary: Intestinal parasitic diseases are a global public health problem which mostly affect developing countries where adequate water and sanitation facilities are lacking. Due to its equatorial climate, vast territory with isolated areas and the precariousness of its population, intestinal parasitosis is considered to be a major issue in French Guiana and came to be frequently detected during hospitalisations. However, only few data are available and no integrated control programs have been conducted. This is the first study that has been exploring and reporting epidemiological data on intestinal parasitic infections in French Guiana covering much of the territory. This work reports an average parasitic index of 16.0%, which was stable between 2011 (18.2%) and 2016 (18.3%) with a majority of Ancylostoma sp, Strongyloides stercoralis and Giardia intestinalis. Although it may not be representative of the entire Guyanese population, the parasitic index remained high and stable from 2011 to 2016 and it justifies the need for an active prevention program as it was already done in the other French overseas departments such as Martinique and Guadeloupe. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
323. Gastrointestinal disseminated histoplasmosis in HIV-infected patients: A descriptive and comparative study.
- Author
-
Nacher, Mathieu, Valdes, Audrey, Adenis, Antoine, Blaizot, Romain, Abboud, Philippe, Demar, Magalie, Djossou, Félix, Epelboin, Loïc, Misslin, Caroline, Ntab, Balthazar, Louvel, Dominique, Drak Alsibai, Kinan, and Couppié, Pierre
- Subjects
- *
HISTOPLASMOSIS , *OPPORTUNISTIC infections , *SYMPTOMS , *HIV infections , *HIV-positive persons , *LIVER enzymes - Abstract
Disseminated histoplasmosis is one the main AIDS-defining opportunistic infections in HIV-infected patients, notably in Latin America. The non-specific and proteiform clinical presentation leads to diagnostic delays that may lead to fatal outcomes. This retrospective multicentric study aimed to describe the frequency and manifestations of gastrointestinal histoplasmosis in French Guiana, and to compare patients with disseminated histoplasmosis with or without gastrointestinal involvement. Between January 1, 1981 and October 1, 2014 co-infections with HIV and histoplasmosis were enrolled. Inclusion criteria were: age >18 years, confirmed HIV infection; first proven episode of histoplasmosis. Among 349 cases of disseminated histoplasmosis, 245 (70%) had a gastrointestinal presentation. Half of patients with gastrointestinal signs had abdominal pain or diarrhea, mostly watery. Half of patients with abdominal pain had diarrhea (63/124) and half of those with diarrhea (63/123) had abdominal pain. A significant proportion of patients also had hepatomegaly and, to a lesser degree, splenomegaly. After adjusting for potential confounding, the presence of lymphadenopathies >2cm (AOR = 0.2, IC95 = 0.04–0.7, P = 0.01), Haitian origin (AOR = 0.04, IC95 = 0.004–0.4, P = 0.006) were associated with a lower prevalence of gastrointestinal signs and positive gastrointestinal presence of H. capsulatum. Persons with a gastrointestinal H. capsulatum were more likely to have a decreased prothrombin time, lower ferritin, lower liver enzymes, and lower concentrations of LDH than those without gastrointestinal signs and symptoms. They also had a shorter interval between symptoms onset and diagnosis. Patients with a positive gastrointestinal identification of H. capsulatum were less likely to die at 1 month than those without a gastrointestinal presentation (respectively, 4.6% vs 18.5%, P = 0.01). Subacute or chronic gastrointestinal presentations are very frequent during disseminated histoplasmosis, they seem less severe, and should lead to suspect the diagnosis in endemic areas. There were populational or geographic differences in the frequency of gastrointestinal manifestations that could not be explained. Author summary: This retrospective multicentric study aimed to describe the frequency and manifestations of gastrointestinal histoplasmosis in French Guiana, and to compare patients with disseminated histoplasmosis with or without gastrointestinal involvement. Between January 1, 1981 and October 1, 2014 co-infections with HIV and histoplasmosis were enrolled. Inclusion criteria were: age >18 years, confirmed HIV infection; first proven episode of histoplasmosis. Among 349 cases of disseminated histoplasmosis, 245 (70%) had a gastrointestinal presentation. Half of patients with gastrointestinal signs had abdominal pain or diarrhea, mostly watery. Half of patients with abdominal pain had diarrhea (63/124) and half of those with diarrhea (63/123) had abdominal pain. A significant proportion of patients also had hepatomegaly and, to a lesser degree, splenomegaly. After adjusting for potential confounding, the presence of lymphadenopathies >2cm, Haitian origin were associated with a lower prevalence of gastrointestinal signs and presence of H. capsulatum. Persons with a gastrointestinal presentation were more likely to have a decreased prothrombin time, lower liver enzyme concentration, ferritin, and lower concentrations of LDH than those without gastrointestinal signs and symptoms. The delay between symptom's onset and diagnosis was also shorter and the proportion of deaths at 1 month was significantly lower among those with gastrointestinal presence of H. capsulatum. Subacute or chronic gastrointestinal presentations are very frequent during disseminated histoplasmosis, they seem less severe, and should lead to suspect the diagnosis in endemic areas. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
324. Resurgence risk for malaria, and the characterization of a recent outbreak in an Amazonian border area between French Guiana and Brazil.
- Author
-
Mosnier, Emilie, Dusfour, Isabelle, Lacour, Guillaume, Saldanha, Raphael, Guidez, Amandine, Gomes, Margarete S., Sanna, Alice, Epelboin, Yanouk, Restrepo, Johana, Davy, Damien, Demar, Magalie, Djossou, Félix, Douine, Maylis, Ardillon, Vanessa, Nacher, Mathieu, Musset, Lise, and Roux, Emmanuel
- Subjects
- *
MALARIA , *PLASMODIUM vivax , *MEDICAL centers , *ANOPHELES - Abstract
Background: In 2017, inhabitants along the border between French Guiana and Brazil were affected by a malaria outbreak primarily due to Plasmodium vivax (Pv). While malaria cases have steadily declined between 2005 and 2016 in this Amazonian region, a resurgence was observed in 2017.Methods: Two investigations were performed according to different spatial scales and information details: (1) a local study on the French Guiana border, which enabled a thorough investigation of malaria cases treated at a local village health center and the entomological circumstances in the most affected neighborhood, and (2) a regional and cross-border study, which enabled exploration of the regional spatiotemporal epidemic dynamic. Number and location of malaria cases were estimated using French and Brazilian surveillance systems.Results: On the French Guianese side of the border in Saint-Georges de l'Oyapock, the attack rate was 5.5% (n = 4000), reaching 51.4% (n = 175) in one Indigenous neighborhood. Entomological findings suggest a peak of Anopheles darlingi density in August and September. Two female An. darlingi (n = 1104, 0.18%) were found to be Pv-positive during this peak. During the same period, aggregated data from passive surveillance conducted by Brazilian and French Guianese border health centers identified 1566 cases of Pv infection. Temporal distribution during the 2007-2018 period displayed seasonal patterns with a peak in November 2017. Four clusters were identified among epidemic profiles of cross-border area localities. All localities of the first two clusters were Brazilian. The localization of the first cluster suggests an onset of the outbreak in an Indigenous reservation, subsequently expanding to French Indigenous neighborhoods and non-Native communities.Conclusions: The current findings demonstrate a potential increase in malaria cases in an area with otherwise declining numbers. This is a transborder region where human mobility and remote populations challenge malaria control programs. This investigation illustrates the importance of international border surveillance and collaboration for malaria control, particularly in Indigenous villages and mobile populations. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
325. HIV patients dying on anti-tuberculosis treatment: are undiagnosed infections still a problem in French Guiana?
- Author
-
Nacher, Mathieu, Adenis, Antoine, Abboud, Philippe, Djossou, Felix, Demar, Magalie, Epelboin, Loïc, and Couppié, Pierre
- Subjects
- *
AIDS-related opportunistic infections , *HIV-positive persons , *OPPORTUNISTIC infections , *TERMINALLY ill , *PNEUMOCYSTIS pneumonia , *PERMIAN-Triassic boundary - Abstract
Objective: Despite scaling-up testing and antiretroviral treatment in Latin America, advanced HIV remains a significant public health problem. The objective of the present study was look for historical risk factors for death in French Guiana's HIV cohort taking into account the immunological status, the main opportunistic infections, and their treatment. A retrospective cohort study was conducted on data collected between 1992 and 2008 to identify factors associated with death in a cohort 2323 patients. Results: There were 370 deaths for a total 9608 patient-years. Being on tuberculosis treatment was associated with a greater hazard of death. The diagnosis of confirmed tuberculosis, of histoplasmosis, of toxoplasmosis, and pneumocystosis were independently associated with death. Interactions terms between cotrimoxazole treatment and pneumocystosis, or between confirmed tuberculosis and tuberculosis treatment showed a protective treatment-effect. All patients having received anti-tuberculosis treatment (n = 347) did not have a final diagnosis of tuberculosis (n = 93). For histoplasmosis, 199 patients received antifungal treatment while 141 were diagnosed as having histoplasmosis. The number of patients on anti-tuberculosis drugs was far greater that the number of patients with confirmed tuberculosis, and these patients on treatment without confirmed tuberculosis had a twofold greater risk of dying. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
326. Dynamics of SARS-CoV-2 lineages in French Guiana in 2020–2021: 4 epidemic waves with cross-influences from Europe and South America.
- Author
-
Miliu, Alexandra, Lavergne, Anne, Succo, Tiphanie, Laizé, Claire, Andrieu, Audrey, Enfissi, Antoine, Enouf, Vincent, Van der Werf, Sylvie, Blanchet, Denis, Demar, Magalie, Carod, Jean-François, Carage, Thierry, Flamand, Claude, Tirera, Sourakhata, Simon-Lorière, Etienne, Rousseau, Cyril, and Rousset, Dominique
- Subjects
- *
COVID-19 , *SARS-CoV-2 , *WHOLE genome sequencing , *EPIDEMICS , *COVID-19 pandemic , *RNA viruses - Abstract
Since the first cases of SARS-CoV-2 infection in Wuhan in December 2019, this RNA virus gave rise to different viral lineages with different virological, epidemiological and immunological properties. Here we describe the dynamics of circulation of SARS-CoV-2 lineages in an Amazonian South American French overseas territory, French Guiana (FG). The data analyzed are based on the general epidemic course, and genomic surveillance data come from whole genome sequencing (WGS) as well as typing PCRs. From March 2020 to October 2021, four COVID-19 epidemic waves were observed in FG with an evolution of viral lineages influenced by virus introductions from continental France and above all by land-based introductions from neighbouring countries. The third epidemic wave from March to June 2021 was driven by a predominant Gamma introduced from Brazil and a less frequent Alpha introduced from France. This coexistence was completely substituted by Delta that initiated the fourth epidemic wave. • France and South America cross-influenced SARS-CoV-2 lineages in French Guiana • High resolution tracking by typing PCRs and NGS • Epidemic waves dynamics 2020–2021 [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
327. Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats.
- Author
-
de Thoisy, Benoît, Duron, Olivier, Epelboin, Loïc, Musset, Lise, Quénel, Philippe, Roche, Benjamin, Binetruy, Florian, Briolant, Sébastien, Carvalho, Luisiane, Chavy, Agathe, Couppié, Pierre, Demar, Magalie, Douine, Maylis, Dusfour, Isabelle, Epelboin, Yanouk, Flamand, Claude, Franc, Alain, Ginouvès, Marine, Gourbière, Sébastien, and Houël, Emeline
- Subjects
- *
VECTOR-borne diseases , *COMMUNICABLE diseases , *EMERGING infectious diseases , *DISEASE vectors , *DISEASE outbreaks , *EPIDEMIOLOGY , *MEDICAL research - Abstract
French Guiana is a European ultraperipheric region located on the northern Atlantic coast of South America. It constitutes an important forested region for biological conservation in the Neotropics. Although very sparsely populated, with its inhabitants mainly concentrated on the Atlantic coastal strip and along the two main rivers, it is marked by the presence and development of old and new epidemic disease outbreaks, both research and health priorities. In this review paper, we synthetize 15 years of multidisciplinary and integrative research at the interface between wildlife, ecosystem modification, human activities and sociodemographic development, and human health. This study reveals a complex epidemiological landscape marked by important transitional changes, facilitated by increased interconnections between wildlife, land-use change and human occupation and activity, human and trade transportation, demography with substantial immigration, and identified vector and parasite pharmacological resistance. Among other French Guianese characteristics, we demonstrate herein the existence of more complex multi-host disease life cycles than previously described for several disease systems in Central and South America, which clearly indicates that today the greater promiscuity between wildlife and humans due to demographic and economic pressures may offer novel settings for microbes and their hosts to circulate and spread. French Guiana is a microcosm that crystallizes all the current global environmental, demographic and socioeconomic change conditions, which may favor the development of ancient and future infectious diseases. • Both scientific and biomedical research tends to work in silos, what the OneHealth and Ecohealth concepts keep hammering. • Zoonotic and vector-borne (ZVBID) infectious diseases form an important group of diseases emerging and reemerging worldwide. • 15 years of research in French Guiana (South America) on ZVBID reveals new insights onto the wildlife-ecosystem-disease nexus. • Environmental, demographic, socioeconomic changes in French Guiana favor the development of ancient and new ZVBID. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
328. Bone and Joint Infections in Children With Sickle Cell Disease in French Guiana: A 13-year Retrospective Multicenter Review.
- Author
-
Furgier A, Goutines J, Dobian S, Zappa M, Demar M, Aigoun N, Oubda B, Faye A, Elenga N, and Osei L
- Abstract
Introduction: Sickle cell disease (SCD) is a genetic disorder with a high infectious morbidity and mortality and a heterogeneous distribution in France. One of the challenges is to differentiate a bone and joint infection (BJI) from a vaso-occlusive crisis. This challenge is particularly prevalent in French Guiana, an overseas territory with the highest incidence of SCD in France. The aim of this study was to describe the epidemiology of BJI in children with SCD in French Guiana., Method: This was a retrospective multicentric descriptive study of SCD patients living in French Guiana aged under 18 and diagnosed with a BJI between 2010 and 2022. These BJI were divided into 2 groups: those with microbiological documentation (d-BJI) and those without microbiological identification (ud-BJI)., Results: A total of 53 episodes of BJI in 42 patients (mean age 7.2 years) were reported. Clinical symptoms on arrival were comparable between the d-BJI and ud-BJI groups. Patients in the d-BJI group had longer average hospital stays (40.4 days vs. 16.8 days, P = 0.01) and Salmonella spp. were the most identified bacteria (n = 8/13). White blood cell count was greater in the d-BJI group (30.3 G/L vs. 18.G/L, P = 0.01) and a collection was more frequently identified on imaging (11/13 vs. 16/40, P = 0.01) in this group. Initial in-hospital antibiotic therapy was longer in the d-BJI group (17.2 days vs. 12.8, P = 0.02), as were infection-related complications (9/13 vs. 12/40 P = 0.01)., Conclusion: BJI in children with SCD is not sufficiently microbiologically documented. Progress must be made to improve the documentation of BJI., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
329. Trends in the Prevalence of Antimicrobial Resistance in Escherichia coli Isolated from Outpatient Urine Cultures in French Amazonia.
- Author
-
Nkontcho Djamkeba F, Sainte-Rose V, Lontsi Ngoulla GR, Roujansky A, Abboud P, Walter G, Houcke S, Demar M, Kallel H, Pujo JM, and Djossou F
- Subjects
- Humans, Female, Male, Retrospective Studies, French Guiana epidemiology, Adult, Middle Aged, Prevalence, Urinary Tract Infections microbiology, Urinary Tract Infections drug therapy, Urinary Tract Infections epidemiology, beta-Lactamases genetics, Drug Resistance, Bacterial, Aged, Trimethoprim, Sulfamethoxazole Drug Combination pharmacology, Young Adult, Escherichia coli drug effects, Escherichia coli isolation & purification, Escherichia coli Infections epidemiology, Escherichia coli Infections microbiology, Escherichia coli Infections drug therapy, Escherichia coli Infections urine, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Outpatients statistics & numerical data, Microbial Sensitivity Tests
- Abstract
Antimicrobial resistance (AMR) in the community is increasing worldwide. We aimed to assess AMR trends in Escherichia coli from the community urine isolates in French Amazonia. We conducted a retrospective study from January 2016 to December 2022 in the Cayenne General Hospital microbiology laboratory (French Guiana). It included all urine samples positive for E. coli collected from adult outpatients. During the study period, 3,443 urinalyses positive for E. coli were studied. In 46% of cases, patients were women. In 64.4% of cases, E. coli were β-lactamase producers. The most frequently diagnosed resistance mechanisms were penicillinase production and sparing third-generation cephalosporins. Isolated E. coli were extended-spectrum β-lactamase (ESBL) producers in 6.1% of cases. Overall, E. coli was susceptible to amoxicillin in 35.9% [95% CI: 34.3-37.5], to amoxicillin/clavulanic acid in 62.2% [95% CI: 60.6-63.9], to cefotaxime in 94% [95% CI: 93.1-94.7], to gentamicin in 92.1% [95% CI: 89.1-92.6], to ofloxacin in 76.8% [95% CI: 75.3-78.2], to trimethoprim/sulfamethoxazole (SXT) in 58.8% [95% CI: 57.1-60.5], to fosfomycin in 99.1% [95% CI: 98.6-99.4], and to nitrofurantoin in 99% of cases [95% CI: 98.6-99.3]. We have observed a gradual decline in the susceptibility profile of E. coli for amoxicillin/clavulanic acid (P <0.001), piperacillin/tazobactam (P = 0.003), and temocillin (P = 0.006). However, susceptibility to ciprofloxacin was increasing (P = 0.001). In contrast, the susceptibility trends for amoxicillin, third-generation cephalosporins, gentamicin, SXT, nitrofurantoin, and fosfomycin remained stable over the 28 quarters of the study. In conclusion, isolated E. coli from outpatient urinalyses showed increased resistance profiles involving penicillinase and ESBL production. Close monitoring and strategies to decrease antibiotic consumption in the community are needed.
- Published
- 2024
- Full Text
- View/download PDF
330. Meat-Borne-Parasite: A Nanopore-Based Meta-Barcoding Work-Flow for Parasitic Microbiodiversity Assessment in the Wild Fauna of French Guiana.
- Author
-
Matoute A, Maestri S, Saout M, Laghoe L, Simon S, Blanquart H, Hernandez Martinez MA, and Pierre Demar M
- Abstract
French Guiana, located in the Guiana Shield, is a natural reservoir for many zoonotic pathogens that are of considerable medical or veterinary importance. Until now, there has been limited data available on the description of parasites circulating in this area, especially on protozoan belonging to the phylum Apicomplexa; conversely, the neighbouring countries describe a high parasitic prevalence in animals and humans. Epidemiological surveillance is necessary, as new potentially virulent strains may emerge from these forest ecosystems, such as Amazonian toxoplasmosis. However, there is no standard tool for detecting protozoa in wildlife. In this study, we developed Meat-Borne-Parasite, a high-throughput meta-barcoding workflow for detecting Apicomplexa based on the Oxford Nanopore Technologies sequencing platform using the 18S gene of 14 Apicomplexa positive samples collected in French Guiana. Sequencing reads were then analysed with MetONTIIME pipeline. Thanks to a scoring rule, we were able to classify 10 samples out of 14 as Apicomplexa positive and reveal the presence of co-carriages. The same samples were also sequenced with the Illumina platform for validation purposes. For samples identified as Apicomplexa positive by both platforms, a strong positive correlation at up to the genus level was reported. Overall, the presented workflow represents a reliable method for Apicomplexa detection, which may pave the way for more comprehensive biomonitoring of zoonotic pathogens.
- Published
- 2024
- Full Text
- View/download PDF
331. Molecular epidemiology of Candida africana isolates collected from vagina swabs in French Guiana.
- Author
-
Bigot J, Kalboussi Y, Bonkoto Nkoy Y, Benmostefa A, Vellaissamy S, Benzerara L, Sainte-Rose V, Blanchet D, Demar M, Guitard J, and Hennequin C
- Subjects
- Female, Humans, French Guiana epidemiology, Molecular Epidemiology, Microbial Sensitivity Tests veterinary, Vagina microbiology, Antifungal Agents, Candida albicans, Candidiasis, Vulvovaginal epidemiology, Candidiasis, Vulvovaginal microbiology, Candidiasis, Vulvovaginal veterinary, Candida
- Abstract
Previous molecular studies have shown that Candida africana corresponds to the clade 13 of Candia albicans. It has been mostly involved in vulvovaginal candidiasis worldwide but few data exist in South America. The aim of our study was to investigate the prevalence of C. africana in women living in French Guiana. For this, we first set up a fluorescent-intercalating-dye-real time Polymerase Chain Reaction (PCR) targeting the hyphal wall protein 1 gene. The test was applied to 212 C. albicans isolates collected from May to August 2019 from vaginal swabs, allowing the identification of six women harboring C. africana (eight isolates). The in vitro susceptibility of these eight isolates to six antifungal drugs was also evaluated. No demographics or clinical-specific features could be demonstrated. Genetic diversity of those isolates was analyzed through multilocus sequence typing and showed that diploid sequence type 182 was predominant (n = 6) and allowed the report of a new diploid sequence type., (© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2024
- Full Text
- View/download PDF
332. Mortality Trend of Severe COVID-19 in Under-Vaccinated Population Admitted to ICU in French Amazonia.
- Author
-
Matheus S, Houcke S, Lontsi Ngoulla GR, Higel N, Ba A, Cook F, Gourjault C, Nkontcho F, Demar M, Nacher M, Djossou F, Hommel D, Résiere D, Pujo JM, and Kallel H
- Abstract
(1) Background: Until December 2021, French Guiana (FG), located in South America, faced four consecutive COVID-19 epidemic waves. This study sought to analyze the mortality trend of severe COVID-19 patients admitted to the referral ICU of FG. (2) Methods: We conducted a prospective, observational, and non-interventional study in ICU at Cayenne Hospital. We included 383 patients older than 18 admitted with SARS-CoV-2-related pneumonia hospitalized from May 2020 to December 2021. The study covers three periods. Period 1 (Waves 1 and 2, original variant), period 2 (Wave 3, Gamma variant), and period 3 (Wave 4, Delta variant). (3) Results: The median age was 63 years (52-70). Frailty was diagnosed in 36 patients over 70 (32.4%). Only 4.8% of patients were vaccinated. The median ICU LOS was 10 days (6-19). Hospital mortality was 37.3%. It was 30.9% in period 1, 36.6% in period 2 ( p = 0.329 vs. period 1), and 47.1% in period 3 (0.015 vs. period 1). In multivariate analysis, independent factors associated with hospital mortality included age greater than 40 years (]40-60 years] OR = 5.2, 95%CI: 1.4-19.5; (]60-70 years] OR = 8.5, 95%CI: 2.2-32; (]70+ years] OR = 17.9, 95%CI: 4.5-70.9), frailty (OR = 5.6, 95%CI: 2.2-17.2), immunosuppression (OR = 2.6, 95%CI: 1.05-6.7), and MV use (OR = 11, 95%CI: 6.1-19.9). This model had an overall sensitivity of 72%, a specificity of 80.4%, a positive predictive value of 68.7%, and a negative predictive value of 82.8%. (4) Conclusions: The mortality of severe COVID-19 patients in French Amazonia was higher during the Delta variant wave. This over-death could be explained by the virulence of the responsible SARS-CoV-2 variant and the under-vaccination coverage of the studied population.
- Published
- 2024
- Full Text
- View/download PDF
333. Cryptococcus neoformans Infections Differ Among Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in France.
- Author
-
Paccoud O, Desnos-Ollivier M, Cassaing S, Boukris-Sitbon K, Alanio A, Bellanger AP, Bonnal C, Bonhomme J, Botterel F, Bougnoux ME, Brun S, Chouaki T, Cornet M, Dannaoui E, Demar M, Desbois-Nogard N, Durieux MF, Favennec L, Fekkar A, Gabriel F, Gangneux JP, Guitard J, Hasseine L, Huguenin A, Le Gal S, Letscher-Bru V, Mahinc C, Morio F, Nicolas M, Rouges C, Cateau E, Persat F, Poirier P, Ranque S, Roosen G, Roux AL, Sasso M, Lortholary O, and Lanternier F
- Abstract
Among 1107 cryptococcosis cases from the French surveillance network (2005-2020), the proportion of HIV-seronegative individuals has recently surpassed that of HIV-seropositive individuals. We observed marked differences in patient characteristics, disease presentations, cryptococcal antigen results, infecting species, and mortality according to HIV serostatus., Competing Interests: Potential conflicts of interest. Over the past 5 years, E. D. has received research grants from MSD, Gilead, and bioMérieux; travel grants from Gilead, MSD, and Pfizer; and speaker's fees from Gilead and Pfizer. All other authors report no potential conflicts of interest., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2023
- Full Text
- View/download PDF
334. Pulmonary Histoplasmosis in People Living with Human Immunodeficiency Virus in French Guiana: Clinical Epidemiology, Medical Imaging and Prognostic.
- Author
-
Bourne-Watrin M, Adenis A, Doppelt G, Zappa M, Epelboin L, Nacher M, Bigot J, Drak Alsibai K, Blaizot R, Blanchet D, Demar M, Guillot G, Djossou F, and Couppié P
- Subjects
- Humans, Adult, HIV, Retrospective Studies, Prognosis, French Guiana epidemiology, Tomography, X-Ray Computed, Histoplasmosis diagnosis, Histoplasmosis epidemiology, Histoplasmosis complications, AIDS-Related Opportunistic Infections diagnosis, Acquired Immunodeficiency Syndrome complications, Lung Diseases, Fungal diagnostic imaging, Lung Diseases, Fungal epidemiology, Pneumonia, Pneumocystis complications, Lung Diseases, Interstitial complications
- Abstract
Background: Histoplasmosis is mainly described as a disseminated disease in people living with HIV (PLHIV). Compared to historical descriptions in immunocompetent individuals, knowledge is lacking on the detailed clinical and radiological findings and outcomes of pulmonary histoplasmosis (PH). Overlooked or misdiagnosed with other AIDS-defining condition, prognostic of PLHIV may be at risk because of inappropriate care., Methods: A retrospective multicentric study was conducted in PLHIV from French Guiana between January 1988 and October 2019. Proven PH were documented through mycological direct examination, culture, or histology. Patients with concomitant respiratory infections were excluded., Results: Among 65 patients, sex ratio M:F was 2.4 with a median age of 39 years [IQR 25-75%: 34-44]. Median CD4 count was 24 cells/mm
3 [11-71], with histoplasmosis as the AIDS-defining condition in 88% and concomitant AIDS-defining conditions in 29%. Clinical findings were fever (89%), cough (58%), dyspnea (35%), expectoration (14%), and hemoptysis (5%). Sixty-one X-rays and 24 CT-scans were performed. On X-rays, an interstitial lung disease was mainly found (77%). On CT-scans, a nodular pattern was predominant (83%): mostly miliary disease (63%), but also excavated nodules (35%). Consolidations were present in 46%, associated with miliary disease in 21%. Thoracic lymphadenopathies were found in 58%, mainly hilar and symmetric (33%). Despite antifungal treatment, case-fatality rate at one month was 22%., Conclusion: When faced with an interstitial lung disease on X-rays or a miliary pattern on CT-scans in advanced PLHIV, physicians in endemic areas, apart from tuberculosis or pneumocystosis, should include histoplasmosis as part of their differential diagnoses., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
335. Factors associated with chronic kidney disease in patients with diabetes in French Guiana.
- Author
-
Sacareau C, Nacher M, Drak Alsibai K, Ntoutoum A, Adenis A, Hounnou M, Liebart M, Cardoso CS, Aurelus JM, Demar M, Casse O, Amokrane S, Carod JF, Hafsi N, and Sabbah N
- Abstract
Introduction: With over half of the population living under the poverty threshold, the social and health context in French Guiana is more difficult than in mainland France. The prevalence of diabetes is twice as great and end-stage renal failure is 45% higher than in mainland France., Objective: Our objective was to describe the profile of diabetic patients with chronic kidney disease in French Guiana and search for possible risk factors., Method: We conducted a multicenter cross-sectional observational study based on the CODIAM cohort (Cohort of Diabetes in French Amazonia). We analyzed 1,287 patients followed up between May 2019 and June 2021 at Cayenne Hospital, Saint Laurent Hospital, and delocalized health centers., Results: In our cohort, chronic kidney disease was present after an average of 12 years of diabetes. Compared with the French population, 41% of diabetic patients had chronic kidney disease (i.e., 12% more), and had an average age of 56 years (i.e., 10 years younger). Forty-eight per cent of these patients were obese (i.e., 7% more). Seventy-four per cent of patients were precarious and 45% were foreigners but neither was associated with chronic kidney disease, contrary to countries where the health system is not universal., Conclusion: Screening of patients with chronic kidney disease among diabetics in French Guiana remains a real challenge. Patients were younger and more obese than in other French territories. In this cohort, precariousness and immigration were not associated with the presence of chronic kidney disease. However, particular attention should be paid to hypertensive patients and those over 65 years of age, which are, with diabetes itself, the two most obvious risk factors for developing chronic kidney disease among diabetic patients in our territory., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Sacareau, Nacher, Drak Alsibai, Ntoutoum, Adenis, Hounnou, Liebart, Cardoso, Aurelus, Demar, Casse, Amokrane, Carod, Hafsi and Sabbah.)
- Published
- 2023
- Full Text
- View/download PDF
336. Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature.
- Author
-
Bonnet PL, Hoffmann CV, Le Nan N, Bellamy L, Hoarau G, Flori P, Demar M, Argy N, Morio F, Le Gal S, and Nevez G
- Subjects
- Animals, Atovaquone therapeutic use, Cytochromes b genetics, Retrospective Studies, Mutation, Pneumocystis carinii genetics
- Abstract
Pneumocystis jirovecii is a transmissible fungus responsible for severe pneumonia (Pneumocystis pneumonia [PCP]) in immunocompromised patients. Missense mutations due to atovaquone selective pressure have been identified on cytochrome b (CYB) gene of P. jirovecii. It was recently shown that atovaquone prophylaxis can lead to the selection of specific P. jirovecii CYB mutants potentially resistant to atovaquone among organ transplant recipients. In this context, our objectives were to provide data on P. jirovecii CYB mutants and the putative selective pressure exerted by atovaquone on P. jirovecii organisms in France. A total of 123 patients (124 P. jirovecii specimens) from four metropolitan hospitals and two overseas hospitals were retrospectively enrolled. Fourteen patients had prior exposure to atovaquone, whereas 109 patients did not at the time of P. jirovecii detection. A 638 base-pair fragment of the CYB gene of P. jirovecii was amplified and sequenced. A total of 10 single nucleotide polymorphisms (SNPs) were identified. Both missense mutations C431T (Ala144Val) and C823T (Leu275Phe), located at the Qo active site of the enzyme, were significantly associated with prior atovaquone exposure, these mutations being conversely incidental in the absence of prior atovaquone exposure (P < 0.001). Considering that the aforementioned hospitals may be representative of the national territory, these findings suggest that the overall presence of P. jirovecii CYB mutants remains low in France., (© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2023
- Full Text
- View/download PDF
337. Diagnostic and Management of Emphysematous Hepatitis with Emphasis on Biopathology.
- Author
-
Porez D, Kallel H, Dobian S, Gerbert-Ferrendier T, Nacher M, Djossou F, Demar M, Amroun H, Zappa M, and Drak Alsibai K
- Abstract
Emphysematous hepatitis is a rare infectious disease, which corresponds to the presence of gas in the liver, without collection and after exclusion of vascular origin. This entity belongs to the group of emphysematous infections, whose physiopathology seems to be linked to the presence of unbalanced diabetes and to bacterial fermentation, leading to the production of gas within the liver parenchyma. Very few cases of emphysematous hepatitis have been described in the literature, and most of them had a rapidly fatal course. In this manuscript, we report the case of a 59-year-old man with emphysematous hepatitis due to wild-type Klebsiella pneumoniae that was successfully managed by surgery, and we perform a review of the literature to describe the clinical and biopathological aspects of this rare hepatic disease. Our manuscript underlines the need to perform biological and histopathological sampling to better understand the pathophysiology of this rare entity. The causes and mechanisms of emphysematous hepatitis, which seem to be multiple, lead us to believe that it is a syndrome rather than a simple infectious disease.
- Published
- 2023
- Full Text
- View/download PDF
338. Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana.
- Author
-
Saidi N, Blaizot R, Prévot G, Aoun K, Demar M, Cazenave PA, Bouratbine A, and Pied S
- Subjects
- Humans, French Guiana epidemiology, Africa, Northern, Cytokines, Leishmaniasis, Cutaneous, Leishmania
- Abstract
Cutaneous leishmaniasis (CL) caused by infection with the parasite Leishmania exhibits a large spectrum of clinical manifestations ranging from single healing to severe chronic lesions with the manifestation of resistance or not to treatment. Depending on the specie and multiple environmental parameters, the evolution of lesions is determined by a complex interaction between parasite factors and the early immune responses triggered, including innate and adaptive mechanisms. Moreover, lesion resolution requires parasite control as well as modulation of the pathologic local inflammation responses and the initiation of wound healing responses. Here, we have summarized recent advances in understanding the in situ immune response to cutaneous leishmaniasis: i ) in North Africa caused by Leishmania (L.) major , L. tropica , and L. infantum , which caused in most cases localized autoresolutives forms, and ii ) in French Guiana resulting from L. guyanensis and L. braziliensis , two of the most prevalent strains that may induce potentially mucosal forms of the disease. This review will allow a better understanding of local immune parameters, including cellular and cytokines release in the lesion, that controls infection and/or protect against the pathogenesis in new world compared to old world CL., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Saidi, Blaizot, Prévot, Aoun, Demar, Cazenave, Bouratbine and Pied.)
- Published
- 2023
- Full Text
- View/download PDF
339. Recurrent vomiting and confusion in pregnancy: hypercalcaemia due to parathyroid adenoma.
- Author
-
Sabbah N, Demar M, Sogbo F, Zappa M, Alsibai KD, Amroun H, and Chanson P
- Subjects
- Female, Pregnancy, Humans, Confusion, Vomiting etiology, Hypercalcemia etiology, Parathyroid Neoplasms complications, Parathyroid Neoplasms diagnostic imaging, Parathyroid Neoplasms surgery
- Abstract
Competing Interests: Declaration of interests We declare no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
340. Case Report: Acute Brucellosis Due to Brucella suis in a Brazilian Gold Miner Diagnosed in French Guiana.
- Author
-
Melzani A, Boutrou M, Sainte-Rose V, About F, Douine M, Michaud C, Nacher M, Gaillet M, Blanchet D, Lavigne JP, Demar M, O'Callaghan D, Djossou F, Keriel A, and Epelboin L
- Subjects
- Animals, Swine, Humans, Adult, Brazil, French Guiana, Zoonoses diagnosis, Sus scrofa, Fever, Brucella suis, Brucellosis diagnosis, Brucellosis drug therapy, Swine Diseases
- Abstract
A 29-year-old Brazilian illegal gold miner developed intermittent fever. Blood cultures were positive for Gram-negative coccobacilli and, after an initial misidentification by an automated identification system, the diagnosis of brucellosis caused by Brucella suis was confirmed. We hypothesize an association with domestic or wild swine exposure. The patient responded well to standard antibiotic therapy of brucellosis. We report the first case of human brucellosis on the Guiana Shield. This report underlines the importance of considering brucellosis in the presence of a fever of unknown origin, even in the Amazonian rainforest area, where several zoonotic diseases might be considered in the differential diagnosis of unexplained fever.
- Published
- 2023
- Full Text
- View/download PDF
341. Human T-cell leukemia virus type 1 is associated with dysthyroidism in the French Amazon.
- Author
-
Dugardin J, Demar M, Hafsi N, Amroun H, Aurelus JM, Drak Alsibai K, Ntoutoum A, Santa F, Nacher M, and Sabbah N
- Subjects
- Adult, Humans, Male, Female, Adolescent, Young Adult, Middle Aged, Aged, Case-Control Studies, French Guiana epidemiology, Prevalence, Human T-lymphotropic virus 1, Hyperthyroidism complications, Hyperthyroidism epidemiology, Hyperthyroidism virology, Hypothyroidism complications, Hypothyroidism epidemiology, Hypothyroidism virology, Leukemia-Lymphoma, Adult T-Cell complications, Leukemia-Lymphoma, Adult T-Cell epidemiology
- Abstract
Background: Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus known to cause two major diseases: adult T-cell leukemia/lymphoma and a progressive neuromyelopathy-tropical spastic paraparesis. Many viruses may be involved in the pathogenesis of thyroiditis; however, few studies have focused on the role of HTLV-1. We aimed to investigate the association between HTLV-1 and biological thyroid dysfunction., Methods: We included 357 patients with a positive HTLV-1 serology and thyroid-stimulating hormone assay data between 2012 and 2021 in a hospital in French Guiana; we compared the prevalence of hypothyroidism and hyperthyroidism in this group with that in an HTLV-1-negative control group (722 persons) matched for sex and age., Results: The prevalence of hypothyroidism and hyperthyroidism in patients with HTLV-1 infection was significantly higher than that in the control group (11% versus 3.2% and 11.3% versus 2.3%, respectively; p < 0.001)., Conclusion: Our study shows, for the first time, the association between HTLV-1 and dysthyroidism in a large sample, suggesting that thyroid function exploration should be systematically implemented in this population as this may have an impact on therapeutic management., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Dugardin, Demar, Hafsi, Amroun, Aurelus, Drak Alsibai, Ntoutoum, Santa, Nacher and Sabbah.)
- Published
- 2023
- Full Text
- View/download PDF
342. Antimicrobial Susceptibility of Community-Acquired Urine Bacterial Isolates in French Amazonia.
- Author
-
NkontCho F, Sainte-Rose V, Abboud P, Portecop P, Pujo JM, Cook F, Walter G, Mounier R, Resiere D, Houcke S, Demar M, Kallel H, and Djossou F
- Subjects
- Adult, Humans, Female, Nitrofurantoin, Escherichia coli, Retrospective Studies, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Amoxicillin-Potassium Clavulanate Combination, Oxacillin, Urinary Tract Infections drug therapy, Urinary Tract Infections epidemiology, Urinary Tract Infections microbiology, Community-Acquired Infections epidemiology
- Abstract
Bacterial resistance in community-acquired urinary tract infections (UTIs) is increasing worldwide. Our study aimed to assess the microbiological epidemiology and antimicrobial susceptibility patterns of community-acquired urine bacterial isolates in French Amazonia. Our study is retrospective. It was conducted from January 2015 to December 2019 in the microbiology laboratory of the Cayenne General Hospital (French Guiana). It includes all positive urine samples from adult (> 18 years) outpatients (N = 2,533). Isolated microorganisms were Gram-negative rods in 83.9%, mainly Enterobacterales (98.4%). The main isolated bacteria were Escherichia coli (58.7%) and Klebsiella pneumoniae (13.3%). Among the isolated E. coli, 37.2% were susceptible to amoxicillin, 77.9% to amoxicillin/clavulanic acid, 94.9% to cefotaxime, 78.9% to ofloxacin, and 98.9% to nitrofurantoin. In 106 cases (5.1%), isolated Enterobacterales were extended-spectrum β-lactamase producers (5% of E. coli and 8.9% of K. pneumoniae). Overall, high levels of cross- and co-resistance were registered. The main isolated Gram-positive bacteria was Staphylococcus saprophyticus (28.9%). It was resistant to oxacillin in 52.5% of cases and susceptible to nitrofurantoin in 99.1% of cases. Patients with S. saprophyticus were young women in almost all cases. In conclusion, the most isolated microorganisms from outpatient urinalyses were E. coli and K. pneumoniae. They showed a high resistance rate to amoxicillin, but they were susceptible to the most remaining antibiotics. S. saprophyticus was isolated mainly in young women and was resistant to oxacillin in half of the cases. Interestingly, nitrofurantoin was active against most isolated organisms and can be considered as empirical treatment in uncomplicated UTIs.
- Published
- 2023
- Full Text
- View/download PDF
343. The burden of COVID-19 in French Guiana: Vaccine-averted deaths, hospitalizations and costs.
- Author
-
Nacher M, Vignier N, Rousseau C, Adenis A, Douine M, Basurko C, de Toffol B, Elenga N, Kallel H, Pujot J, Zappa M, Demar M, Djossou F, Couppié P, and Epelboin L
- Abstract
Objectives: French Guiana, the least-vaccinated French territory, also has the lowest COVID-19 vaccination coverage in Latin America. We aimed to estimate how many deaths, hospitalizations and costs the vaccines had and could have avoided., Methods: We calculated the Number Needed to Vaccinate to prevent one death per year, 1 standard hospitalization, 1 Intensive Care Unit admission given the mean incidence numbers of the past 6 months, and divided the number of persons vaccinated to estimate how many deaths and hospitalizations had been avoided in French Guiana at that time., Results: The crude number needed to vaccinate to prevent one death per year, the crude number needed to vaccinate to prevent one hospitalization per 6 months were computed Based on our observed incidence and ICU admission rate, the crude number needed to vaccinate to prevent one ICU admission per 6 months.After 6 months with an incidence exceeding 400 per million inhabitants, and 148 observed deaths, we estimate that vaccination avoided 46 deaths (IC95%=43.5-48.7). If the number of vaccinated persons had reached the same proportion as mainland France, 141 deaths per year could have been prevented (IC95%=131.9-147.6).With 2085 hospitalization and 370 ICU admissions during the same period, we estimate that the current albeit low vaccination rate avoided 300 hospital (IC95%=280-313) and 77 (IC95%=72-81) ICU admissions. With the same vaccination rates as mainland France, we estimate that 900 hospitalizations and 231 ICU admissions would have been avoided.Similarly, there would have been 139 ICU admission (instead of 370)., Conclusions: In sparsely populated French Guiana these numbers are quite substantial and framing the vaccine benefits and wasted opportunities using such concrete numbers may help convincing undecided persons to get vaccinated., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
344. [Overview of infectious and non-infectious diseases in French Guiana in 2022].
- Author
-
Epelboin L, Abboud P, Abdelmoumen K, About F, Adenis A, Blaise T, Blaizot R, Bonifay T, Bourne-Watrin M, Boutrou M, Carles G, Carlier PY, Carod JF, Carvalho L, Couppié P, De Toffol B, Delon F, Demar M, Destoop J, Douine M, Droz JP, Elenga N, Enfissi A, Franck YK, Fremery A, Gaillet M, Kallel H, Kpangon AA, Lavergne A, Le Turnier P, Maisonobe L, Michaud C, Mutricy R, Nacher M, Naldjinan-Kodbaye R, Oberlis M, Odonne G, Osei L, Pujo J, Rabier S, Roman-Laverdure B, Rousseau C, Rousset D, Sabbah N, Sainte-Rose V, Schaub R, Sylla K, Tareau MA, Tertre V, Thorey C, Vialette V, Walter G, Zappa M, Djossou F, and Vignier N
- Subjects
- Animals, Humans, French Guiana epidemiology, Communicable Diseases, Cuniculidae, Histoplasmosis, HIV Infections, Noncommunicable Diseases, Q Fever, Toxoplasmosis diagnosis
- Abstract
Source of many myths, French Guiana represents an exceptional territory due to the richness of its biodiversity and the variety of its communities. The only European territory in Amazonia, surrounded by the Brazilian giant and the little-known Suriname, Ariane 6 rockets are launched from Kourou while 50% of the population lives below the poverty line. This paradoxical situation is a source of health problems specific to this territory, whether they be infectious diseases with unknown germs, intoxications or chronic pathologies.Some infectious diseases such as Q fever, toxoplasmosis, cryptococcosis or HIV infection are in common with temperate countries, but present specificities leading to sometimes different management and medical reasoning. In addition to these pathologies, many tropical diseases are present in an endemic and / or epidemic mode such as malaria, leishmaniasis, Chagas disease, histoplasmosis or dengue. Besides, Amazonian dermatology is extremely varied, ranging from rare but serious pathologies (Buruli ulcer, leprosy) to others which are frequent and benign such as agouti lice (mites of the family Trombiculidae) or papillonitis. Envenomations by wild fauna are not rare, and deserve an appropriate management of the incriminated taxon. Obstetrical, cardiovascular and metabolic cosmopolitan pathologies sometimes take on a particular dimension in French Guiana that must be taken into account in the management of patients. Finally, different types of intoxication are to be known by practitioners, especially due to heavy metals.European-level resources offer diagnostic and therapeutic possibilities that do not exist in the surrounding countries and regions, thus allowing the management of diseases that are not well known elsewhere.Thanks to these same European-level resources, research in Guyana occupies a key place within the Amazon region, despite a smaller population than in the surrounding countries. Thus, certain pathologies such as histoplasmosis of the immunocompromised patient, Amazonian toxoplasmosis or Q fever are hardly described in neighboring countries, probably due to under-diagnosis linked to more limited resources. French Guiana plays a leading role in the study of these diseases.The objective of this overview is to guide health care providers coming to or practicing in French Guiana in their daily practice, but also practitioners taking care of people returning from French Guiana., (Copyright © 2023 SFMTSI.)
- Published
- 2023
- Full Text
- View/download PDF
345. Impact of Antibiotic Consumption on the Acquisition of Extended-Spectrum β-Lactamase Producing Enterobacterales Carriage during the COVID-19 Crisis in French Guiana.
- Author
-
Lontsi Ngoula G, Houcke S, Matheus S, Nkontcho F, Pujo JM, Higel N, Ba A, Cook F, Gourjault C, Mounier R, Nacher M, Demar M, Djossou F, Hommel D, and Kallel H
- Abstract
(1) Background: During the COVID-19 outbreak, several studies showed an increased prevalence of extended-spectrum β-lactamase producing Enterobacterales (ESBL-PE) carriage in intensive care units (ICUs). Our objective was to assess the impact of antibiotic prescriptions on the acquisition of ESBL-PE in ICUs during the COVID-19 crisis. (2) Methods: We conducted an observational study between 1 April 2020, and 31 December 2021, in the medical-surgical ICU of the Cayenne General Hospital. We defined two periods: Period 1 with routine, empirical antibiotic use, and Period 2 with no systematic empiric antibiotic prescription. (3) Results: ICU-acquired ESBL-PE carriage was 22.8% during Period 1 and 9.4% during Period 2 ( p = 0.005). The main isolated ESBL-PE was Klebsiella pneumoniae (84.6% in Period 1 and 58.3% in Period 2). When using a generalized linear model with a Poisson family, exposure to cefotaxime was the only factor independently associated with ESBL-PE acquisition in ICU ( p = 0.002, IRR 2.59 (95% IC 1.42-4.75)). The propensity scores matching estimated the increased risk for cefotaxime use to acquire ESBL-PE carriage at 0.096 (95% CI = 0.02-0.17), p = 0.01. (4) Conclusions: Exposure to cefotaxime in patients with severe COVID-19 is strongly associated with the emergence of ESBL-PE in the context of maximal infection control measures.
- Published
- 2022
- Full Text
- View/download PDF
346. Leishmaniasis epidemiology in endemic areas of metropolitan France and its overseas territories from 1998 to 2020.
- Author
-
Pasquier G, Demar M, Lami P, Zribi A, Marty P, Buffet P, Desbois-Nogard N, Gangneux JP, Simon S, Blaizot R, Couppié P, Thiebaut L, Pratlong F, Dedet JP, Bastien P, Sterkers Y, Ravel C, and Lachaud L
- Subjects
- Humans, France epidemiology, West Indies, Leishmania infantum, Leishmaniasis, Mucocutaneous, Leishmaniasis, Cutaneous
- Abstract
Background: In France, leishmaniasis is endemic in the Mediterranean region, in French Guiana and to a lesser extent, in the French West Indies. This study wanted to provide an updated picture of leishmaniasis epidemiology in metropolitan France and in its overseas territories., Methodology/principal Findings: Leishmaniasis cases were collected by passive notification to the French National Reference Centre for Leishmaniases (NRCL) in Montpellier from 1998 to 2020 and at the associated Centre in Cayenne (French Guiana) from 2003 to 2020. In metropolitan France, 517 autochthonous leishmaniasis cases, mostly visceral forms due to Leishmania infantum (79%), and 1725 imported cases (French Guiana excluded), mainly cutaneous leishmaniasis from Maghreb, were recorded. A slight decrease of autochthonous cases was observed during the survey period, from 0.48 cases/100,000 inhabitants per year in 1999 (highest value) to 0.1 cases/100,000 inhabitants per year in 2017 (lowest value). Conversely, imported cases increased over time (from 59.7 in the 2000s to 94.5 in the 2010s). In French Guiana, 4126 cutaneous and mucocutaneous leishmaniasis cases were reported from 2003 to 2020. The mean incidence was 103.3 cases per 100,000 inhabitants/year but varied in function of the year (from 198 in 2004 to 54 in 2006). In Guadeloupe and Martinique (French West Indies), only sporadic cases were reported., Conclusions/significance: Because of concerns about disease expansion and outbreaks in other Southern Europe countries, and leishmaniasis monitoring by the NRCL should be continued and associated with a more active surveillance., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
347. Q Fever as a Cause of Community-Acquired Pneumonia in French Guiana.
- Author
-
Epelboin L, Mahamat A, Bonifay T, Demar M, Abboud P, Walter G, Drogoul AS, Berlioz-Arthaud A, Nacher M, Raoult D, Djossou F, and Eldin C
- Subjects
- Case-Control Studies, French Guiana epidemiology, Humans, Retrospective Studies, Community-Acquired Infections epidemiology, Coxiella burnetii, Pneumonia complications, Q Fever complications, Q Fever diagnosis, Q Fever epidemiology
- Abstract
In French Guiana, community-acquired pneumonia (CAP) represents over 90% of Coxiella burnetii acute infections. Between 2004 and 2007, we reported that C. burnetii was responsible for 24.4% of the 131 CAP hospitalized in Cayenne. The main objective of the present study was to determine whether the prevalence of Q fever pneumonia remained at such high levels. The secondary objectives were to identify new clinical characteristics and risk factors for C. burnetii pneumonia. A retrospective case-control study was conducted on patients admitted in Cayenne Hospital, between 2009 and 2012. All patients with CAP were included. The diagnosis of acute Q fever relied on titers of phase II IgG ≥ 200 and/or IgM ≥ 50 or seroconversion between two serum samples. Patients with Q fever were compared with patients with non-C. burnetii CAP in bivariate and multivariate analyses. During the 5-year study, 275 patients with CAP were included. The etiology of CAP was identified in 54% of the patients. C. burnetii represented 38.5% (106/275; 95% CI: 31.2-45.9%). In multivariate analysis, living in Cayenne area, being aged 30-60 years, C-reactive protein (CRP) > 185 mg/L, and leukocyte count < 10 G/L were independently associated with Q fever. The prevalence of Q fever among CAP increased to 38.5%. This is the highest prevalence ever reported in the world. This high prevalence justifies the systematic use of doxycycline in addition to antipneumococcal antibiotic regimens.
- Published
- 2022
- Full Text
- View/download PDF
348. [Sacroiliitis with Erysipelothrix Rhusiopathiae revealing tricuspid endocarditis, the first case reported on the Guiana Shield: clinical case and review of the literature].
- Author
-
Kheng M, Alexis JF, Walter G, Mosnier É, Malmontet T, Pierre Demar M, Tauch V, Vesin G, Abboud P, Roques F, Djossou F, and Epelboin L
- Subjects
- Animals, Female, Humans, Middle Aged, Ceftriaxone therapeutic use, Ciprofloxacin therapeutic use, Erysipelothrix, Erysipelothrix Infections diagnosis, Sacroiliitis complications, Endocarditis complications
- Abstract
We report here an atypical case of acute sacroiliitis caused by Erysipelothrix rhusiopathiae revealing tricuspid endocarditis in a 53-year-old woman without medical history. She was admitted to Cayenne hospital because of intense right hip and thigh pain, associated with fever. A right sacroiliitis was visible on the computed tomography (CT) scan, confirmed on MRI. Transesophageal echocardiography revealed a large mobile tricuspid vegetation. Blood cultures were positive for E. rhusiopathiae . CT scan showed pulmonary alveolar opacities, consistent with septic emboli. Clinical improvement was obtained under ceftriaxone followed by ciprofloxacin for 6 weeks of treatment. We present a review of bone and joint infections caused by E. rhusiopathiae . So far, not a single case has been reported in Latin America., (Copyright © 2022 SFMTSI.)
- Published
- 2022
- Full Text
- View/download PDF
349. Precariousness, Diabetes Control and Complications in French Guiana.
- Author
-
Linière S, Nacher M, Drak Alsibai K, Mergeayfabre M, Hafsi N, Charpin A, Misslin-Tritsch C, Carod JF, Aurelus JM, De Toffol B, Ntoutoum A, Kakamba JB, Demar M, Helene-Pelage J, Adenis A, and Sabbah N
- Subjects
- French Guiana epidemiology, Glycated Hemoglobin, Glycemic Control, Humans, Prospective Studies, Diabetes Mellitus
- Abstract
Aims: The social parameters of an individual impact the incidence of cardiovascular diseases. French Guiana, an overseas French territory with a lower standard of living than France, has a prevalence of diabetes mellitus that is twice that of mainland France. In this context we aimed to study the relation between precariousness, diabetes complications and glycemic control., Methods: A multicenter prospective cohort was initiated since May 2019. 1243 patients were included and their outcomes and history were compared between the precarious and non-precarious based on their EPICES score, a score that measures social isolation and precariousness., Results: 73.3% of the sample was considered precarious. Retinopathy was significantly more frequent among the deprived. There were no significant differences for other macro or microvascular complications.There was a significant difference in Glycated Haemoglobin between the precarious and non-precarious groups (8.3% (67 mmol/l) vs 8.8% (73mmol/l)). After adjusting for potential confounders, precariousness was no longer associated with poor glycemic control; the independent factors significantly associated with poor glycemic control were: not being fluent in French, having creole or portugese as mother language, and not having any insurance., Conclusions: Precariousness is a risk factor for retinal complications in patients with diabetes mellitus in French Guiana. In this chronic disease, the universal healthcare system alleviates health inequalities for many, but not all, diabetic complications.Translation and cultural mediation may further reduce health inequalities in this multicultural territory where a substantial proportion of the population is not fluent in French., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Linière, Nacher, Drak Alsibai, Mergeayfabre, Hafsi, Charpin, Misslin-Tritsch, Carod, Aurelus, De Toffol, Ntoutoum, Kakamba, Demar, Helene-Pelage, Adenis and Sabbah.)
- Published
- 2022
- Full Text
- View/download PDF
350. Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018).
- Author
-
Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, Favennec L, Cateau E, Bailly E, Moniot M, Bonhomme J, Desbois-Nogard N, Chouaki T, Paugam A, Bouteille B, Pihet M, Dalle F, Eloy O, Sasso M, Demar M, Mariani-Kurkdjian P, Robert V, Lortholary O, and Dromer F
- Subjects
- Aged, Antifungal Agents therapeutic use, Humans, Watchful Waiting, Aspergillosis drug therapy, Aspergillosis epidemiology, Fungemia drug therapy, Invasive Fungal Infections epidemiology, Mucormycosis drug therapy, Pneumonia, Pneumocystis
- Abstract
The French National Reference Center for Invasive Mycoses and Antifungals leads an active and sustained nationwide surveillance program on probable and proven invasive fungal diseases (IFDs) to determine their epidemiology in France. Between 2012 and 2018, a total of 10,886 IFDs were recorded. The incidence increased slightly over time (2.16 to 2.36/10,000 hospitalization days, P = 0.0562) in relation with an increase of fungemia incidence (1.03 to 1.19/10,000, P = 0.0023), while that of other IFDs remained stable. The proportion of ≥65-year-old patients increased from 38.4% to 45.3% ( P < 0.0001). Yeast fungemia ( n = 5,444) was due mainly to Candida albicans (55.6%) with stable proportions of species over time. Echinocandins became the main drug prescribed (46.7% to 61.8%), but global mortality rate remained unchanged (36.3% at 1 month). Pneumocystis jirovecii pneumonia ( n = 2,106) was diagnosed mostly in HIV-negative patients (80.7%) with a significantly higher mortality than in HIV-positive patients (21.9% versus 5.4% at 1 month, P < 0.0001). Invasive aspergillosis ( n = 1,661) and mucormycosis ( n = 314) were diagnosed mostly in hematology (>60% of the cases) with a global mortality rate of 42.5% and 59.3%, respectively, at 3 months and significant changes in diagnosis procedure over time. More concurrent infections were also diagnosed over time (from 5.4% to 9.4% for mold IFDs, P = 0.0115). In conclusion, we observed an aging of patients with IFD with a significant increase in incidence only for yeast fungemia, a trend toward more concurrent infections, which raises diagnostic and therapeutic issues. Overall, global survival associated with IFDs has not improved despite updated guidelines and new diagnostic tools. IMPORTANCE The epidemiology of invasive fungal diseases (IFDs) is hard to delineate given the difficulties in ascertaining the diagnosis that is often based on the confrontation of clinical and microbiological criteria. The present report underlines the interest of active surveillance involving mycologists and clinicians to describe the global incidence and that of the main IFDs. Globally, although the incidence of Pneumocystis pneumonia, invasive aspergillosis, and mucormycosis remained stable over the study period (2012 to 2018), that of yeast fungemia increased slightly. We also show here that IFDs seem to affect older people more frequently. The most worrisome observation is the lack of improvement in the global survival rate associated with IFDs despite the increasing use of more sensitive diagnostic tools, the availability of new antifungal drugs very active in clinical trials, and a still low/marginal rate of acquired in vitro resistance in France. Therefore, other tracks of improvement should be investigated actively.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.